Search results

chimera (PROTAC) is a molecule that can remove specific unwanted proteins. Rather than acting as a conventional enzyme inhibitor, a PROTAC works by inducing...

initial work focused on the discovery of PROteolysis-TArgeting Chimeras (PROTACs) to trigger degradation of disease-causing proteins, a process known as...

operating companies in France, Italy, and the UK, working with Bayern-Chemie/Protac in Germany, Inmize Sistemas SL in Spain, and Saab Bofors Dynamics in Sweden...

of PROTACs, which consist of a heterobifunctional molecule with a ligand of an E3 ubiquitin ligase linked to a ligand of a target protein. PROTACs are...

proteolysis-targeting chimera or PROTAC and its therapeutic potential. Recruitment of an E3 ligase to the target protein by the PROTAC is a critical step in the...

Pulses". Economic Botany. 61 (1): 108. doi:10.1663/0013-0001(2007)61[108a:PROTAC]2.0.CO;2. ISSN 0013-0001. S2CID 198156564. McLelland, Jonathan (4 December...

the pool of potential protein targets. Proteolysis-targeting chimeras (PROTACs) were first reported by Kathleen Sakamoto, Craig Crews, and Raymond Deshaies...

SHR9549: Jiangsu Hengrui Vepdegestrant (ARV-471): Oral estrogen receptor PROTAC protein degrader for breast cancer by Arvinas. ZB716 (Fulvestrant boronic...

conceived the idea of using heterobifunctional small molecules, referred to as PROTACs, to tether cellular proteins to a ubiquitin ligase, resulting in ubiquitination...

Elizabeth; Chen, Xin; Haskell, Roy; Lin, Eva (2022-11-10). "Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers"...

Brd4, Brd4-BD2 L387A, that can be highly selectively bound by tag-specific PROTAC degrader AGB1 to form a ternary complex between the "BromoTagged" protein...

heterobifunctional (two-sided) synthetic small molecules such as dimerizers or PROTACs bring two proteins together inside cells, which can synthetically induce...

using the novel drug modality of proteolysis-targeting-chimeras (PROTACs). PROTACs are heterobifunctional small molecules that are designed to interact...

profiling enables high-throughput screening for PROteolysis TArgeting Chimera (PROTAC) phenotypic signature". doi:10.1101/2022.01.17.476610. Retrieved 2023-08-13...

proteins of interest. These molecules, termed proteolysis targeting chimeras (PROTACs) or protein degraders, recruit CRBN to a protein of interest, leading to...

assessing ternary complex formation. An example for such modulators are PROTACs, which are investigated for their therapeutic potential in cancer therapy...

for gene therapy . These discoveries led Steve Crews at Yale to develop PROTACS for the selective degradation of therapeutic targets. More recently, Crabtree...

Zhang Z, Wang J, Shen Z (January 2021). "Proteolysis targeting chimera (PROTAC) in drug discovery paradigm: Recent progress and future challenges". Eur...

analog of the ERK5 inhibitor BAY-885 the Proteolysis Targeting Chimera (PROTAC) INY-06-061 was developed which allows to compare the phenotypes resulting...

and new ligands that expand the scope of proteolysis targeting chimeras (PROTACS), which are bifunctional molecules that harness the cells ubiquitin-proteasome...